GROG

Migration sur Bluesky ---> grog-studygroup.bsky.social

Among participants receiving oxytocin in early labour, discontinuing oxytocin when the active phase is reached does not clinically or statistically significantly reduce neonatal morbidity compared with continuous oxytocin. @TheLancet @LeRayGO @audeglt pubmed.ncbi.nlm.nih.gov/37952548/

The early use of intrauterine balloon tamponade did not reduce the incidence of severe postpartum hemorrhage compared with its use after the failure of second-line uterotonic treatment and before recourse to invasive procedures @AJOG_thegray pubmed.ncbi.nlm.nih.gov/37209893/

@APHP @Inserm @univ_paris_cite Fière de cet essai et de cette belle publication avec @audeglt et le @GROG_StudyGroup

Pluriannual meeting of the GROG Study Group in Paris. Great research projects in perspective. #Obstetrics #Team #Research

Our correspondence in The Lancet about FRENCH-ARRIVE after serious, evidence-free, and false accusation of unethical research. With the support of Ben W Mol and colleagues for the need for appropriate language in the debate on medicalisation of pregnancy.

Several members of the GROG study group are present at the 6th European Congress on Intrapartum Care to present their work #ECIC2023 #Belgrade 👏

Some of the GROG study group (Groupe de Recherche en Obstétrique et Gynécologie) members at the #SMFM23 meeting to proudly represent French research in obstetrics!

Arrêt de l'#oxytocine pendant la phase active du 1er stade du travail, l’essai randomisé français STOPOXY avec près de 2500 patientes incluses (1192 vs 1175) : pas de différence de morbidité néonatale, du mode d'accouchement, des indications de césarienne #SMFM2023 👏 @audeglt

Discontinuation of #oxytocin during the active first stage of #labor, the French RCT STOPOXY which included almost 2500 patients (1192 vs 1175): no difference in neonatal morbidity, mode of delivery, indications for C/S. #SMFM2023 👏 @audeglt

New article from the TRAAP2 Study Group : « Surgeons’ gender was not associated with maternal morbidity after a cesarean delivery ». #TRAAP2 ja.ma/3kC9Ta5 @CHUBordeaux @Epope_Inserm @GROG_StudyGroup @JAMASurgery @JAMANetwork

In #TwinPregnancies, the risk of severe #PostPartumHemorrhage increases from 2% for sum of twins' birthweights below 3000 grams to 9% for sum exceeding 6500g (i.e. 35% risk increase for +500g in sum of birthweigths) #JUMODA @greenjrnl @GROG_StudyGroup journals.lww.com/greenjournal/A…

📣 🚨 Le rapport de l’Enquête Nationale Périnatale 2021 est sorti aujourd’hui #ENP #perinatalite #grossesse #accouchement #naissances Le rapport complet est disponible sur le site enp.inserm.fr

Alternative to intensive management of the active phase of the second stage of labor: a multicenter randomized trial (PASST trial) among nulliparous women with an epidural - A, Intervention (moderate pushing) group. B, Control (intensive pushing) group. ow.ly/uVm350KZAey

Publication PASST trial @GROG_StudyGroup Alternative to intensive management of the active phase of the second stage of labor: a multicenter randomized trial among nulliparous women with an epidural ajog.org/article/S0002-…

Premiers résultats de l’essai BETADOSE sur une réduction de dose de 50 % du traitement anténatal par la bétaméthasone donné pour prévenir les complications de la prématurité : aphp.fr/contenu/premie… @HopRobertDebre | @Inserm | @univ_paris_cite

Neonatal outcomes for women at risk of preterm delivery given half dose versus full dose of antenatal betamethasone: a randomised, multicentre, double-blind, placebo-controlled, non-inferiority trial. ⁦@TheLancet⁩ #section-3d6acba1-acea-4be2-8dc9-b7e14e5b6583" target="_blank" rel="nofollow noopener">thelancet.com/journals/lance…

Among women with a multiple pregnancy and cesarean delivery, prophylactic tranexamic acid did not reduce the incidence of any blood loss-related outcomes. #TRAAP2SecondaryAnalysis @AJOG_thegray

Planned cesarean delivery for very preterm twins is not associated with better survival to discharge without severe neonatal morbidity than planned vaginal delivery. @greenjrnl #Preterm #TwinPregnancy #NeonatalMorbidity #JUMODA journals.lww.com/greenjournal/F…